
Kirsten Lynn Greene MD
Surgical Oncology
Professor and Chair UVA Urology
Join to View Full Profile
500 Ray C Hunt DrCharlottesville, VA 22903
Phone+1 434-924-2224
Fax+1 434-244-9481
Dr. Greene is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified urologic cancer surgeon and Chair of the Department of Urology at the University of Virginia. My interests include robotic surgery, prostate cancer outcomes and imaging, and medical education.
Education & Training
UCSFM.A.S., Clinical Research, 2006 - 2008
University of California (San Francisco)Residency, Urology, 2002 - 2006
University of California (San Francisco)Residency, Surgery, 2000 - 2002
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2028
VA State Medical License 2019 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- The 2025 Urology Match: Results From the Society of Academic Urologists Program Director Survey.Srinath-Reddi Pingle, Michael Creswell, Sarah Faris, Kirsten Greene, Christopher Keel
Urology. 2025-10-01 - 1 citationsThe 2025 Urology Match: Results From the Society of Academic Urologists Medical Student Survey.Srinath-Reddi Pingle, Ezra J Margolin, Michael Creswell, Sarah Faris, Kirsten Greene
Urology. 2025-07-21 - 6 citationsTrends in Urology Residency Applications: Results From the American Urological Association Medical Student Survey From 2022 to 2024.Michael Creswell, Kirsten Greene, Lee Richstone, Simone Thavaseelan, Erica Traxel
Urology. 2025-05-01
Journal Articles
- First-in-Human Phase I Study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate CancerSpencer C Behr, Hao G Nguyen, Thomas A Hope, Kirsten L Greene, Matthew R Cooperberg, Robert R Flavell, Eric J Small, Peter R Carroll, Journal of Nuclear Medicine
Press Mentions
New Test Locates Prostate Cancer’s SpreadJanuary 6th, 2021
New Scan Finds Prostate Cancer Cells Hiding in the BodyDecember 16th, 2020
Thanks. Feedback Improves Google AdsOctober 16th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









